|
|
Management Team
“If I could solve all the problems myself, I would.”
- Thomas Edison, Inventor and Businessman, when asked why he had a team of twenty-one assistants (1847–1931)
The CHA team has direct, extensive experience in the biopharmaceutical industry. We bring together complementary skill sets and approach collaboration with the same degree of innovation we used in R&D. We have a deep understanding of the industry and a keen ability to see it objectively. Our clients include virtually all global biopharmaceutical companies, including the world's largest pharmaceutical companies.
Senior Management
Charlie Hoban
Chief Executive Officer
Eugene Williams (formerly with Genzyme)
Founder, Strategic Advisor
Andrew Branca
Senior Vice President, Strategic Research
Ernest Bush, Ph.D. (formerly with F. Hoffman-La Roche)
Vice President & Scientific Director, Safety Science
Eric Glazer
Vice President, Marketing
Eric Meyers
Vice President, Global Initiatives
Frank Attardo
Senior Project Director
Haizhou Zhang (formerly Boehringer Ingelheim)
Vice President, China Operations
CHA Partners
Robert Bruno, Ph.D. (formerly with Bristol-Myers Squibb)
Project Director
John Donovan, D.V.M. (formerly Wyeth)
Scientific Director
Jack Reynolds, D.V.M. (formerly with Pfizer)
Chairman of Advisory Board, Drug Safety Executive Council and Special Advisor
Ellen Sheehey
Consultant and Project Director
|